NCT04815590View on ClinicalTrials.gov

Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose

UnknownOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

October 17, 2023

Study Completion Date

October 17, 2023

Conditions
Opioid-Use DisorderOpioid Overdose
Trial Locations (1)

V6Z 1Y6

RECRUITING

Rapid Access Addiction Clinic (RAAC), St. Paul's Hospital, Vancouver

Sponsors

Collaborators (1)

Indivior Inc.
All Listed Sponsors
collaborator

Indivior Inc.

INDUSTRY

lead

BC Centre on Substance Use

OTHER

NCT04815590 - Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose | Biotech Hunter | Biotech Hunter